Assessing Mitsui Chemicals (TSE:4183) Valuation After FY2026 Results And Recent Share Price Momentum

Mitsui Chemicals (TSE:4183) has released full year results for the period ended March 31, 2026, reporting sales of ¥1,668,754 million, net income of ¥34,378 million, and basic earnings per share of ¥91.62.

See our latest analysis for Mitsui Chemicals.

The earnings release appears to have coincided with a sharp shift in sentiment, with the share price up 16.16% over the past month and the 1 year total shareholder return at 47.41%. This suggests momentum has recently picked up after a softer 3 month patch.

If these moves have you thinking about where else capital could work hard, it may be worth scanning for opportunities in robotics and automation via our 34 robotics and automation stocks

With shares up 47.41% over the past year and trading only about 2% below one analyst price target and an intrinsic estimate, the key question is whether Mitsui Chemicals is still undervalued or if the market is already pricing in future growth.

Most Popular Narrative: 26.2% Undervalued

Against the last close at ¥2,213.5, the most followed narrative points to a fair value of ¥3,000, framing Mitsui Chemicals as materially mispriced today.

While analysts broadly agree that restructuring and optimization will boost net margins, Mitsui Chemicals' aggressive asset light strategy, demonstrated by rapid divestiture of commoditized businesses and early capacity shutdowns, positions the company for a sharper than expected uplift in group wide margins, operating leverage, and capital efficiency in the coming years.

Read the complete narrative.

Want to see what sits behind that confidence in higher margins and cash generation? The full narrative leans on faster profit growth, rising efficiency, and a lower future earnings multiple to get to ¥3,000.

Result: Fair Value of ¥3,000 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this hinges on cleaner execution, with regulatory issues and pressure in Basic & Green Materials both capable of cutting into margins and cash returns.

Find out about the key risks to this Mitsui Chemicals narrative.

Another Angle: What The P/E Is Telling You

The fair value story at ¥3,000 leans heavily on future earnings and buybacks, but the current P/E of 23.3x paints a different picture. It is higher than the JP Chemicals industry at 13.1x, yet close to the 24.7x fair ratio and well below the 48.6x peer average, so the stock carries both upside and compression risk depending on which group the market follows next.

To see how this gap between current P/E, industry, peers, and the fair ratio could matter for your own risk tolerance, See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Given the mix of optimism and caution in this story, it makes sense to look at the numbers yourself and decide where you stand. After that, you can weigh up the 3 key rewards and 2 important warning signs.

Looking for more investment ideas?

If you stop with just one stock, you risk missing other opportunities that may better fit your goals, risk tolerance, or income needs, so keep looking.

• Target long term value by scanning companies that currently screen as 16 high quality undervalued stocks, so you can see where quality and pricing might line up for you.
• Strengthen your income focus by reviewing stocks in the 45 dividend fortresses and see which yield profiles could complement your existing holdings.
• Protect your downside by checking out the 58 resilient stocks with low risk scores and shortlist companies that may offer more resilient fundamentals for the next stage of your portfolio.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.